STLN

Healthcare Medical Care Facilities

Starling Oncology, Inc.

$6.35
+0.13 +2.09% today

Price History

Not enough data

Key Stats

Market Cap
647.17M
Avg Volume
1.58M
EPS
-$0.29
52W High
$7.13
52W Low
$2.32
Div. Yield
0.0%

Analyst Ratings

Buy
1
Str Buy
4
Buy
0
Hold
0
Sell
0
Str Sell

Valuation

P/B Ratio
-25.60
P/S Ratio
1.10
EV/EBITDA
-36.87
EV/Revenue
1.21

Margins

Gross Margin 15.7%
Operating Margin (2.9%)
Net Margin (6.2%)
EBITDA Margin (3.3%)

Growth & Returns

Revenue Growth (YoY)
34.6%
Return on Assets
(9.6%)

Liquidity & Leverage

Current Ratio
1.36
Quick Ratio
1.14
Total Cash
41.09M
Total Debt
104.79M

About

Starling Oncology, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other. The company offers physician services, in-house infusion, in-house specialty pharmacy, clinical trials, radiation therapy, and outpatient blood product transfusion services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance and support services. It also manages clinical trials and palliative care programs; operates combined community clinics and infusion suites; and operates a specialty pharmacy that includes both in-office and mail-order dispensing for complementary oral and self-injectable medications taken by patients concurrent with their in-office cancer therapies. It serves adult and senior cancer patients. The company was formerly known as The Oncology Institute, Inc. and changed its name to Starling Oncology, Inc. in August 2026. Starling Oncology, Inc. was founded in 2007 and is headquartered in Cerritos, California.

starlingoncology.com